Illumina spending more than $1 billion to acquire Pacific Biosciences, increase its IP portfolio
November 05, 2018 | News Commentary
Illumina is making another significant step to consolidate its ownership of the next-generation sequencing (NGS) space. Its flagship short-read NGS technology is already the dominant approach for most applications across food,...
About Lux Research
Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.